Literature DB >> 3891337

Treatment of Pseudomonas aeruginosa septicemia in neutropenic patients with ceftazidime.

B E de Pauw, T de Witte, J T Janssen, C Haanen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3891337     DOI： 10.1007/bf02013603

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.

Authors:  C Singer; M H Kaplan; D Armstrong
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

2.  Pseudomonas bacteremia in patients with malignant diseases.

Authors:  J P Whitecar; M Luna; G P Bodey
Journal:  Am J Med Sci       Date:  1970-10       Impact factor: 2.378

3.  Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients.

Authors:  B E de Pauw; F Kauw; H Muytjens; K J Williams; T Bothof
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

4.  Ceftazidime in patients with Pseudomonas infections.

Authors:  L J Eron; C H Park; D L Hixon; R I Goldenberg; D M Poretz
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

5.  Ceftazidime treatment in intensive care patients.

Authors:  R van Dalen; H L Muytjens; J S Gimbrère
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

6.  An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa.

Authors:  A Bauernfeind
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790
  6 in total
  1 in total

1.  [Results of several different controlled studies with ceftazidime in the treatment of infections in immunosuppressed patients].

Authors:  B E de Pauw
Journal:  Infection       Date:  1987       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.